Medication info
Rosuro Tablet 10mg (Rosuvastatin Calcium)

Rosuro Tablet 10mg (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Chong Kun Dang Pharmaceutical Corp.
Appearance
Pink circular film-coated tablet
Packaging
30 tablets per box [10 tablets/PTP x 3], 30 tablets per bottle
Approval status
Active

MFDS item code 200810870 · Approved 2008.11.07 · Insurance code 643305080

Summary

Main use
Improvement of dyslipidemia, reduction of cardiovascular risk, and suppression of atherosclerosis progression
Who takes it
Adults · Children
Adult dose
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of the day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to achieve control in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients : No dosage adjustment is required. 4. Patients with renal impairment : No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Special caution is required when administering this medicine at 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : The recommended initial dose is 5 milligrams for Asian patients because systemic exposure to this medicine is increased in these patients. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose is 5 milligrams for patients predisposed to myopathy. Administration of the 40-milligram dose is contraindicated in some of these patients.
Child dose
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
Chong Kun Dang Pharmaceutical Corp.

Efficacy & effects

Improvement of dyslipidemia, reduction of cardiovascular risk, and suppression of atherosclerosis progression

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL-cholesterol
  • smoking
  • family history of early coronary heart disease
View approved original text

This medication is used as an adjunct in patients with primary hypercholesterolemia and mixed dyslipidemia when diet and exercise alone are inadequate. It is particularly useful for patients with familial hypercholesterolemia, as it lowers total cholesterol and LDL-cholesterol levels, delaying the progression of atherosclerosis. It can also be administered as a dietary adjunct in pediatric patients aged 10 to 17 who meet specific criteria. Moreover, it is used for reducing the risk of stroke, myocardial infarction, and revascularization in adults at high risk for cardiovascular diseases. It effectively helps in managing blood lipids and preventing cardiovascular diseases.

How to take

Adult dose

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of the day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient to achieve control in most patients. The maintenance dose should be appropriately adjusted at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Elderly patients : No dosage adjustment is required. 4. Patients with renal impairment : No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Special caution is required when administering this medicine at 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : The recommended initial dose is 5 milligrams for Asian patients because systemic exposure to this medicine is increased in these patients. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose is 5 milligrams for patients predisposed to myopathy. Administration of the 40-milligram dose is contraindicated in some of these patients.

Child dose

Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Precautions

This drug should not be used in certain patients. For example, patients with allergies to any component of this drug, severe liver dysfunction, muscle disorders, severe renal impairment, pregnant or lactating women, and those taking specific medications should not be administered this drug. Before taking this drug, regular liver function tests and muscle-related tests are required, and patients with a history of liver disease or heavy alcohol consumption should exercise extra caution. Symptoms such as muscle pain, weakness, or cramps should be reported to medical personnel immediately. This drug can interact with other medications, so if patients are taking other medications, they must inform their doctor or pharmacist. Particularly, the risk of muscle damage may increase when taken with certain antiviral agents, immunosuppressants, antibiotics, and fibrate derivatives. Women of childbearing potential should use appropriate contraceptive methods, and this drug should not be taken during pregnancy. Additionally, breastfeeding women should avoid taking this medication. In cases of overdose, there is no specific antidote, so treatment should be symptomatic, and monitoring of liver function and muscle enzyme levels is necessary. Patients may experience dizziness while taking this drug, so caution should be exercised when driving or operating machinery. Lastly, this drug may rarely cause serious skin reactions or damage to the liver, kidneys, and muscles, so any unusual symptoms should prompt immediate consultation with healthcare providers.

Side effects

Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms, morbilliform drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, hepatic failure, cognitive impairment, ALT elevation, chest pain, muscle cramps, gout, erectile dysfunction, AST elevation, numbness, sensory disturbance, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is important to maintain the storage temperature between 1 degree and 30 degrees Celsius to ensure the medication's effectiveness.

Appearance and packaging

Appearance

Pink circular film-coated tablet

Package unit

30 tablets per box [10 tablets/PTP x 3], 30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.